Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.176 Q1 | 254 | 26 | 65 | 10316 | 1412 | 65 | 22.15 | 396.77 | |
2 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | |
3 | Advanced Drug Delivery Reviews | journal | 3.475 Q1 | 366 | 137 | 485 | 28532 | 7293 | 443 | 13.84 | 208.26 | |
4 | Medicinal Research Reviews | journal | 2.868 Q1 | 150 | 81 | 162 | 16520 | 2023 | 160 | 12.29 | 203.95 | |
5 | Pharmacology and Therapeutics | journal | 3.461 Q1 | 233 | 151 | 450 | 30790 | 5501 | 450 | 11.71 | 203.91 | |
6 | Natural Product Reports | journal | 2.703 Q1 | 211 | 78 | 200 | 12856 | 2264 | 193 | 11.27 | 164.82 | |
7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.730 Q2 | 82 | 18 | 43 | 2951 | 201 | 43 | 4.93 | 163.94 | |
8 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | |
9 | RSC Drug Discovery Series | book series | 0.105 Q4 | 13 | 12 | 256 | 1740 | 75 | 36 | 0.34 | 145.00 | |
10 | Frontiers in Anti-infective Drug Discovery | book series | 0.103 Q4 | 3 | 1 | 8 | 141 | 0 | 7 | 0.00 | 141.00 | |
11 | Journal of Angiotherapy | journal | 2 | 2 | 5 | 274 | 0 | 5 | 0.00 | 137.00 | ||
12 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.513 Q1 | 99 | 16 | 53 | 2147 | 345 | 49 | 5.33 | 134.19 | |
13 | Annual Review of Pharmacology and Toxicology | journal | 4.968 Q1 | 224 | 33 | 90 | 4408 | 1273 | 90 | 13.16 | 133.58 | |
14 | Drug Metabolism Reviews | journal | 1.023 Q1 | 108 | 27 | 78 | 3586 | 437 | 78 | 4.53 | 132.81 | |
15 | Topics in Medicinal Chemistry | book series | 0.373 Q3 | 15 | 34 | 113 | 4308 | 74 | 6 | 0.66 | 126.71 | |
16 | Current Medicinal Chemistry | journal | 0.934 Q1 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | |
17 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.106 Q4 | 1 | 6 | 7 | 732 | 0 | 3 | 0.00 | 122.00 | |
18 | Interdisciplinary Toxicology | journal | 0.297 Q3 | 38 | 6 | 74 | 725 | 102 | 74 | 1.12 | 120.83 | |
19 | Expert Opinion on Therapeutic Targets | journal | 1.964 Q1 | 106 | 103 | 291 | 12152 | 1629 | 257 | 5.41 | 117.98 | |
20 | Cancer Drug Discovery and Development | book series | 0.103 Q4 | 8 | 14 | 115 | 1651 | 49 | 7 | 0.59 | 117.93 | |
21 | Nano Today | journal | 5.586 Q1 | 175 | 128 | 153 | 15010 | 2993 | 153 | 19.62 | 117.27 | |
22 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 13 | 47 | 1511 | 145 | 45 | 3.38 | 116.23 | ||
23 | Critical Reviews in Toxicology | journal | 1.092 Q1 | 129 | 51 | 122 | 5828 | 604 | 121 | 4.76 | 114.27 | |
24 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 29 | 7 | 25 | 793 | 51 | 0 | 2.38 | 113.29 | ||
25 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.031 Q1 | 100 | 95 | 323 | 10735 | 1351 | 299 | 4.04 | 113.00 | |
26 | Cellular and Molecular Life Sciences | journal | 2.928 Q1 | 261 | 313 | 876 | 35261 | 7378 | 869 | 8.64 | 112.65 | |
27 | NTP Immunotoxicity Technical Report Series | book series | 0 | 3 | 0 | 335 | 0 | 0 | 0.00 | 111.67 | ||
28 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.205 Q4 | 2 | 7 | 7 | 778 | 4 | 2 | 0.57 | 111.14 | |
29 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | |
30 | Expert Opinion on Emerging Drugs | journal | 0.975 Q2 | 54 | 41 | 78 | 4420 | 273 | 76 | 3.70 | 107.80 | |
31 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | |
32 | Handbook of Experimental Pharmacology | journal | 1.605 Q1 | 110 | 105 | 380 | 11026 | 1324 | 30 | 3.09 | 105.01 | |
33 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | |
34 | EPMA Journal | journal | 1.177 Q1 | 52 | 39 | 108 | 4020 | 677 | 106 | 6.61 | 103.08 | |
35 | Reference Series in Phytochemistry | book series | 19 | 123 | 252 | 12656 | 212 | 39 | 0.78 | 102.89 | ||
36 | Expert Opinion on Drug Discovery | journal | 1.316 Q1 | 84 | 123 | 320 | 12439 | 1736 | 266 | 4.77 | 101.13 | |
37 | Pharmacological Research | journal | 1.850 Q1 | 169 | 598 | 1048 | 58728 | 7342 | 971 | 6.90 | 98.21 | |
38 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 3 | 7 | 289 | 0 | 7 | 0.00 | 96.33 | ||
39 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q2 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | |
40 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | |
41 | NTP Research Report Series | book series | 3 | 3 | 12 | 282 | 8 | 12 | 0.40 | 94.00 | ||
42 | Expert Review of Precision Medicine and Drug Development | journal | 0.387 Q3 | 16 | 43 | 115 | 4041 | 151 | 91 | 1.39 | 93.98 | |
43 | Journal of NeuroImmune Pharmacology | journal | 1.219 Q1 | 91 | 69 | 162 | 6473 | 611 | 149 | 3.23 | 93.81 | |
44 | Expert Opinion on Therapeutic Patents | journal | 1.121 Q1 | 88 | 71 | 253 | 6591 | 1462 | 244 | 6.40 | 92.83 | |
45 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | |
46 | Expert Opinion on Drug Delivery | journal | 1.084 Q1 | 133 | 133 | 320 | 12076 | 1939 | 291 | 6.14 | 90.80 | |
47 | Current Topics in Medicinal Chemistry | journal | 0.706 Q2 | 133 | 240 | 735 | 21755 | 2287 | 620 | 2.65 | 90.65 | |
48 | Expert Opinion on Orphan Drugs | journal | 0.237 Q3 | 27 | 49 | 228 | 4388 | 166 | 216 | 0.68 | 89.55 | |
49 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | |
50 | Neurotherapeutics | journal | 2.496 Q1 | 136 | 154 | 292 | 13488 | 2091 | 270 | 6.61 | 87.58 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®